Combination of cetuximab with radio-chemotherapy in patients with esophageal cancer: less is more!

about

Anti-tumor efficacy of theliatinib in esophageal cancer patient-derived xenografts models with epidermal growth factor receptor (EGFR) overexpression and gene amplification.

P2860

Q41612476-B71A008E-8E13-4D2D-884C-909C5C429B93

P2860

Combination of cetuximab with radio-chemotherapy in patients with esophageal cancer: less is more!

Item

http://www.wikidata.org/entity/Q43102462

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Combination of cetuximab with ...... ophageal cancer: less is more!

@en

Combination of cetuximab with ...... ophageal cancer: less is more!

@nl

type

Item

label

Combination of cetuximab with ...... ophageal cancer: less is more!

@en

Combination of cetuximab with ...... ophageal cancer: less is more!

@nl

prefLabel

Combination of cetuximab with ...... ophageal cancer: less is more!

@en

Combination of cetuximab with ...... ophageal cancer: less is more!

@nl

P1476

Combination of cetuximab with ...... ophageal cancer: less is more!

@en

P2093

Melanie Kripp

http://www.w3.org/2001/XMLSchema#string

Ralf-Dieter Hofheinz

http://www.w3.org/2001/XMLSchema#string

Sylvie Lorenzen

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Promising outcomes of definitive chemoradiation and cetuximab for patients with esophageal squamous cell carcinoma

Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.

Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results.

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial.

Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial.

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.

Resistance to cetuximab in EGFR-overexpressing esophageal squamous cell carcinoma xenografts due to FGFR2 amplification and overexpression.

P304

E629-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3978/J.ISSN.2072-1439.2015.12.31

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26793377

http://www.w3.org/2001/XMLSchema#string

P921

cetuximab

P932

4703643

http://www.w3.org/2001/XMLSchema#string

Combination of cetuximab with radio-chemotherapy in patients with esophageal cancer: less is more!

about

P2860

P2860

Combination of cetuximab with radio-chemotherapy in patients with esophageal cancer: less is more!

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932